Velocity Fund Partners

Founded in 2016, Velocity Fund Partners is a private equity firm that targets product development and healthcare services in the life sciences industry. The company was launched by two CEOs with diverse but highly complementary backgrounds: One came from healthcare management, and the other from life sciences. They have assembled a team of accomplished leaders in operations and finance and set out to identify research programs or startup companies with a distinct scientific advantage and the opportunity to dramatically change or enhance the development of devices and drugs, diagnosis, or treatment of drugs.

Kenneth Melani MD

Managing Partner

2 past transactions

MedMe Health

Seed Round in 2021
MedMe Health is a patient care platform to help pharmacists schedule, conduct, and track clinical services at scale - both virtually and on-site at your pharmacy.

InClinica

Acquisition in 2016
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in the U.K., Israel, and Malaysia/Singapore. InClinica is a global clinical CRO that specializes in leading companies through clinical trials. The company was founded in 2016 through the acquisition of an existing global clinical CRO. Our senior management team has more than a century of internal drug development experience. We have experience in multiple diseases and device technologies, conducted across all stages of clinical trials, in North America, Asia/Pacific, Europe and Latin America.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.